Encompass Health (EHC) Stock
Leading US provider of rehabilitation and home health. Here's the price, business snapshot, and what's worth knowing about Encompass Health in November 2026.
Encompass Health Corporation (EHC) is a leading US provider of post‑acute healthcare services, operating inpatient rehabilitation hospitals alongside home health and hospice services. Investors should know its revenue is driven largely by inpatient admissions, therapy intensity and occupancy rates, while the home health division offers a complementary, growing revenue stream. The company benefits from demographic trends (an ageing population), scale advantages and a track record of bolt‑on acquisitions, but is exposed to Medicare reimbursement rules, payor mix shifts, labour costs and local referral patterns. Financial performance can fluctuate with policy changes, seasonal demand and hospital referral relationships. Market capitalisation is around $12.6bn, reflecting investor expectations for steady post‑acute demand and margin improvement, though returns are not guaranteed. This information is general and educational only, not personal financial advice; investors should assess suitability, risks and consult a financial adviser before investing.
Encompass Health (EHC) Stock Forecast
Analyst price target, next 12 months
$126.53
+2.0% vs today's $124.09
Price range over the last 12 months
Close to its 12-month high
Analysts covering Encompass Health have a consensus 12-month target of $126.53, above the current price of $124.09.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 25 Oct 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts strongly recommend buying Encompass Health's stock with a target price of $126.53, indicating significant growth potential.
Financial Health
Encompass Health is showing strong revenue and profit margins, indicating solid financial performance.
Dividend
Encompass Health's dividend yield of 0.61% is low, indicating limited income for investors seeking dividends. If you invested $1000, you would be paid $6.10 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Rehab‑care demand
An ageing population and higher post‑acute needs can support steady demand for inpatient rehab and therapy services, though occupancy and local referrals can cause variability.
Policy and reimbursement
Revenue is sensitive to Medicare rules and payor mix; regulatory changes can materially affect margins and growth prospects, so policy risk is important to monitor.
Acquisitions and scale
Growth through bolt‑on acquisitions and expanding home health services can boost scale and efficiencies, but integration and regional demand differences carry execution risk.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
